A multi-center open-label, phase I/II clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ICP-192 in patients with advanced solid tumors and FGFR gene alterations

Project: Research

Project Details

StatusActive
Effective start/end date30/09/21 → 29/09/26

Keywords

  • multicentre trial
  • treatment safety
  • treatment efficacy
  • Pharmacokinetics
  • solid tumours